← Browse by Condition
Medical Condition

breast cancer triple negative

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT07188246 Phase 2
Recruiting

Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Enrollment
40 pts
Location
Canada
Sponsor
London Health Sciences Centre ...
View Trial →
NCT05877859
Recruiting

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Enrollment
10 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT06532812 Phase 1, Phase 2
Recruiting

TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

Enrollment
85 pts
Location
China
Sponsor
Essen Biotech
View Trial →